Interpreting SPRINT: How low should you go?
Cited by 8
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
|The Lancet Diabetes & Endocrinology|2019|330
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease
|Hypertension|2015|183
Serum Bicarbonate and Mortality in Stage 3 and Stage 4 Chronic Kidney Disease
|Clinical Journal of the American Society of Nephrology|2011|181
Fenestrated endovascular grafting: The renal side of the story
|Journal of Vascular Surgery|2005|172